APA (7th ed.) Citation

Moore, R. G., Brown, A. K., Miller, M. C., Badgwell, D., Lu, Z., Allard, W. J., . . . Lu, K. (2008). Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecologic oncology, 110(2), 196-201. https://doi.org/10.1016/j.ygyno.2008.04.002

Chicago Style (17th ed.) Citation

Moore, Richard G., Amy K. Brown, M. Craig Miller, Donna Badgwell, Zhen Lu, W. Jeffrey Allard, C.O Granai, Robert C. Bast, and Karen Lu. "Utility of a Novel Serum Tumor Biomarker HE4 in Patients with Endometrioid Adenocarcinoma of the Uterus." Gynecologic Oncology 110, no. 2 (2008): 196-201. https://doi.org/10.1016/j.ygyno.2008.04.002.

MLA (9th ed.) Citation

Moore, Richard G., et al. "Utility of a Novel Serum Tumor Biomarker HE4 in Patients with Endometrioid Adenocarcinoma of the Uterus." Gynecologic Oncology, vol. 110, no. 2, 2008, pp. 196-201, https://doi.org/10.1016/j.ygyno.2008.04.002.